MEPs accuse the European Commission of caving in to US pharmaceutical interests after a trade deal with Trump.
Emese Grancsa
International
Credit: Jacquelyn Martin / AP / Profimedia
Always see our news on Google
Ursula von der Leyen has been criticized by cross-party MEPs over the trade deal with Donald Trump, which excludes pharmaceuticals from tariffs but allows a 15% cap. Many voices in the European People's Party (EPP) and other political groups believe the deal favors the US and weakens the European Union's position. Additional critics are calling for transparency and publication of the details of the deal, pointing out that while economically it is an improvement, it is a political defeat for the EU.
Sources
Eurodeputaţii o acuză pe Ursula von der Leyen că și-a depășit mandatul și a cedat în faţa intereselor americane
Eurodeputații critică acordul negociat de către Ursula von der Leyen cu Donald Trump: „Ambele părţi trebuie să câştige ceva”
'O zi sumbră pentru Europa'. Franța critică acordul comercial dintre UE și SUA
UE: „Nu am luat încă nicio decizie cu privire la web tax”
Latest News
12:35
Two industrial installations in Russia, including an Ozon warehouse, were hit by debris from Ukrainian drones, with no reported casualties.
12:14
Person on board a ship in the Black Sea, in the Neptun Deep area, urgently evacuated by a Black Hawk helicopter
11:57
A tourist fell 30 meters from a cliff during a hike in the Ceahlău Massif / He was transported by SMURD helicopter to the hospital
11:47
A Chinese humanoid robot ran 100 meters in 9.39 seconds, breaking the world record held by Usain Bolt.
11:28
Serbia thanks Romania for the help provided in extinguishing the vegetation fires
See more news
NEWS ON THE SAME TOPICS
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
